Literature DB >> 8817339

Clustering of mutations in the biotin-binding region of holocarboxylase synthetase in biotin-responsive multiple carboxylase deficiency.

L Dupuis1, A Leon-Del-Rio, D Leclerc, E Campeau, L Sweetman, J M Saudubray, G Herman, K M Gibson, R A Gravel.   

Abstract

Holocarboxylase synthetase (HCS) catalyses the biotinylation of the four biotin-dependent carboxylases found in humans. A deficiency in HCS results in biotin-responsive multiple carboxylase deficiency (MCD). We have identified six different point mutations in the HCS gene in nine patients with MCD. Two of the mutations are frequent among the MCD patients analyzed. Four of the mutations cluster in the putative biotin-binding domain as deduced from the corresponding Escherichia coli enzyme and consistent with an explanation for biotin-responsiveness based on altered affinity for biotin. The two others may define an additional domain involved in biotin-binding or biotin-mediated stabilization of the protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8817339     DOI: 10.1093/hmg/5.7.1011

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Molecular analysis of new Japanese patients with holocarboxylase synthetase deficiency.

Authors:  O Sakamoto; Y Suzuki; Y Aoki; X Li; M Hiratsuka; K Yanagihara; K Inui; T Okabe; S Yamaguchi; J Kudoh; N Shimizu; K Narisawa
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

2.  The polypeptide Syn67 interacts physically with human holocarboxylase synthetase, but is not a target for biotinylation.

Authors:  Yousef I Hassan; Hideaki Moriyama; Janos Zempleni
Journal:  Arch Biochem Biophys       Date:  2009-12-21       Impact factor: 4.013

3.  Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.

Authors:  B R Akerman; M R Natowicz; M M Kaback; M Loyer; E Campeau; R A Gravel
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Holocarboxylase synthetase deficiency: report of a case with onset in late infancy.

Authors:  E Touma; T Suormala; E R Baumgartner; B Gerbaka; H Ogier de Baulny; J Loiselet
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

5.  Holocarboxylase synthetase is an obligate participant in biotin-mediated regulation of its own expression and of biotin-dependent carboxylases mRNA levels in human cells.

Authors:  R Sergio Solórzano-Vargas; Diana Pacheco-Alvarez; Alfonso León-Del-Río
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

6.  Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.

Authors:  Wen-Qi Zeng; Eiman Al-Yamani; James S Acierno; Susan Slaugenhaupt; Tammy Gillis; Marcy E MacDonald; Pinar T Ozand; James F Gusella
Journal:  Am J Hum Genet       Date:  2005-05-03       Impact factor: 11.025

7.  A novel molecular mechanism to explain biotin-unresponsive holocarboxylase synthetase deficiency.

Authors:  Lungisa Mayende; Rachel D Swift; Lisa M Bailey; Tatiana P Soares da Costa; John C Wallace; Grant W Booker; Steven W Polyak
Journal:  J Mol Med (Berl)       Date:  2011-09-06       Impact factor: 4.599

8.  Gamma-ray up-regulated holocarboxylase synthetase gene.

Authors:  Kuke Ding; Chunjie Yang; Jingjing Shen; Lili Xu; Yanling Li; Pinkun Zhou; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2008-12-02       Impact factor: 5.046

9.  Impaired biotinidase activity disrupts holocarboxylase synthetase expression in late onset multiple carboxylase deficiency.

Authors:  Anylu Pérez-Monjaras; Rafael Cervantes-Roldán; Iván Meneses-Morales; Roy A Gravel; Sandra Reyes-Carmona; Sergio Solórzano-Vargas; Alfonso González-Noriega; Alfonso León-Del-Río
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.